Recombinant antibodies in cancer therapy.
The application of recombinant immunotoxin and radioimmunoconjugate in Cancer therapy has revived the "magic bullet" concept predicted a century ago. Many of the recombinant antibodies have received FDA approval for various indication of cancer in recent years and numerous others are in clinical trials.
Nayeem
M S
MS
Department of Chemistry, Aligarh Muslim University, Aligarh-202 002, India.
Khan
Rizwan H
RH
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D016499:Radioimmunotherapy; D011994:Recombinant Proteins / Q000276:immunology / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D011994:Recombinant Proteins